Citadel Advisors’s Macrocure Ltd. MCUR Stock Holding History

Citadel Advisors’s Portfolio MCUR Stock Details MCUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-13,903	Closed	-$20K	–	8368
2016 Q2	$20K	Sell	13,903 -1,048	-7%	-$1.18K	﹤0.01%	6621
2016 Q1	$13K	Buy	+14,951	New	+$15.3K	﹤0.01%	6577

Other funds holding MCUR

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Citadel Advisors's MCUR Position: Q3 2016 in Review

Citadel Advisors sold out of Macrocure Ltd. (MCUR) in Q3 2016, closing a stake of 13,903 shares — an estimated $20K sold.

Citadel Advisors first reported a position in MCUR in Q1 2016 and held it in 2 quarters. The position peaked at $20K in Q2 2016. 7 funds tracked by Wall St. Rank hold MCUR as of Q3 2016.

Citadel Advisors reported no remaining Macrocure Ltd. position as of Q3 2016 after selling out during the quarter.
Citadel Advisors sold 13,903 Macrocure Ltd. shares in Q3 2016, an estimated $20K.
Citadel Advisors first reported a position in Macrocure Ltd. in Q1 2016 and held it in 2 quarters.
Citadel Advisors's Macrocure Ltd. position peaked at $20K in Q2 2016.
7 funds tracked by Wall St. Rank held Macrocure Ltd. as of Q3 2016.

Based on Citadel Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.